HIV/AIDS Vaccines

Immunizations given before you get tainted are called "preventive antibodies" or "prophylactic immunizations," and you get them while you are sound. This permits your body to set up barriers against those perils early. HIV assaults and devastates the disease battling CD4 cells of the safe framework. The loss of CD4 cells makes it troublesome for the body to battle contaminations and certain diseases. Without treatment HIV can steadily pulverize the resistant framework and progress to AIDS. A restorative HIV antibody is an immunization that is intended to enhance the body's insusceptible reaction to HIV in a man who is as of now tainted with HIV. There are at present no restorative HIV immunizations affirmed by the Food and Drug Administration yet research is under way. Researchers are exploring therapeutic

HIV vaccines:

 (1) To slow down the progression of HIV infection,

(2) To eliminate the need for antiretroviral therapy (ART) while still keeping undetectable levels of HIV

(3) As part of a larger strategy to eliminate all HIV viruses from the body.

  • Advances in HIV Vaccine
  • Preclinical & Clinical HIV vaccines research
  • Microbicides for sexually Transmitted Diseases
  • HIV Vaccine development from Animal Models
  • Recombinant Vector Vaccines
  • Stem cell Transplantation
  • Age acceleration effects due to HIV infection
  • Attenuated Virus Vaccines in HIV Infection

Related Conference of HIV/AIDS Vaccines

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA
August 09-10, 2018

27th Euro Congress on Cancer Science & Therapy

Madrid, Spain

HIV/AIDS Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in